


Cytognomix
Biotechnology Research • London, Ontario, Canada • 1-10 Employees
Company overview
| Headquarters | 60 N Centre Rd, POB 27052, London, Ontario N5X 3X5, CA |
| Websites | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Microarrays, Next Generation Sequencing, Dna Probes, Fluorescence In Situ Hybridization, Software For Next Generation Sequencing |
| Founded | 2009 |
| Employees | 1-10 |
| Socials |
Key Contact at Cytognomix
Peter Rogan
President
About Cytognomix
Cytognomix’s proprietary Single Copy (sc) technology brings precise, sensitive, and informative genetic disease management tools to advanced clinical laboratories for detection of chromosome anomalies related to genetic disease. Cytognomix designs and produces molecular cytogenetic tests using fluorescent in-situ hybridization scFISH probes. In addition, microarray-based comparative genomic hybridization (aCGH) can use SC technology to increase reproducibility and reduce cost per sample. A key Cytognomix tool is our proprietary genome browser interface that simplifies selection of single copy probes for nearly any gene-mapped disease. Cytognomix’s scFISH probes will assure correct diagnosis and make possible more personalized treatment than conventional approaches.
Cytognomix revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Cytognomix has never raised funding before.
Cytognomix Tech Stack
Discover the technologies and tools that power Cytognomix's digital infrastructure, from frameworks to analytics platforms.
WordPress plugins
Page builders
Web servers
Font scripts
Miscellaneous
JavaScript libraries
Programming languages
Blogs
WordPress themes
Analytics
Widgets
Frequently asked questions
4.8
40,000 users



